Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SPRB stock hub

Spruce Biosciences, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SPRBis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

152.7M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

SPRB

In the news

Latest news · SPRB

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-109.2

P25 -105.6P50 -46.5P75 -3.1

ROIC-47.8

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SPRB market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

178

Groups with data

Currency

USD

Showing 178 of 178 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001683553
Company name	Spruce Biosciences, Inc.
Country	United States
Country code	US
Cusip	85209E208
Employees	8
Employees Change	-13%
Employees Change Percent	-61.9
Enterprise value	$104.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US85209E2081
Last refreshed	2026-05-10
Market cap	$152.7M
Market cap category	Micro-Cap
Price	$56.5
Price currency	USD
Sector	Healthcare
Symbol	SPRB
Website	https://sprucebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-25.52%
FCF yield	-21.83%
P/B ratio	1.82x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-13.6M
Net Income	$-39M
Net Income Growth Quarters	3%
Net Income Growth Years	1%
Profit Per Employee	$-4.9M
ROA	-36.41
Roa5y	-32.76
ROCE	-66.64
ROE	-109.2
Roe5y	-71.97
ROIC	-47.79

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	935.03%
Cagr3y	-31.06%
Cagr5y	-45.32%
EPS Growth Quarters	3
EPS Growth Years	1
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$53M
Cash	$48.9M
Current Assets	$52.1M
Current Liabilities	$10.1M
Debt	$736,000
Debt Equity	$0.02
Equity	$42.5M
Interest Coverage	-317.9
Liabilities	$10.5M
Long Term Assets	$909,000
Long Term Liabilities	$419,000
Net Cash	$48.2M
Net Cash By Market Cap	$31.55
Net Cash Growth	33.85%
Net Debt Equity	$-1.13
Tangible Book Value	$42.5M
Tangible Book Value Per Share	$30.99
WACC	22.38

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.17
Net Working Capital	$-6.6M
Quick ratio	5.11
Working Capital	$42M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-39.34%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	933.38%
200-day SMA	65.71
3Y total return	-67.25%
50-day SMA	60.88
50-day SMA vs 200-day SMA	50under200
5Y total return	-95.11%
All Time High	2,670
All Time High Change	-97.88%
All Time High Date	2020-11-27
All Time Low	4.28
All Time Low Change	1,221.64%
All Time Low Date	2025-04-29
ATR	4.39
Beta	3.31
Beta1y	-32.77
Beta2y	-10.44
Ch YTD	-35.14
High	57.5
High52	240
High52 Date	2025-10-07
High52ch	-76.46%
Low	56.2
Low52	4.35
Low52 Date	2025-06-10
Low52ch	1,198.85%
Ma50ch	-7.2%
Price vs 200-day SMA	-14.02%
RSI	44.14
RSI Monthly	44.34
RSI Weekly	45.96
Sharpe ratio	1.02x
Sortino ratio	18.84
Total Return	-39.34%
Tr YTD	-35.14
Tr1m	-9.09%
Tr1w	-1.36%
Tr3m	-21.96%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	5
Analyst Count Top	3
Analyst Price Target Top	$204
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-7.32
Operating Income	$-28.6M
Price target	$191
Price Target Change	$237
Price Target Change Top	$262

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	2,603,426%
Float Percent	96.34%
Net Borrowing	-2,057,000
Shares Insiders	3.66%
Shares Institutions	34.28%
Shares Out	2,702,278
Shares Qo Q	130.49%
Shares Yo Y	39.34%
Short Float	6.93%
Short Ratio	3.41
Short Shares	6.68

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-35.9M
Average Volume	89,920.8x
Bv Per Share	30.99
Ch1m	-9.09
Ch1w	-1.36
Ch1y	933.3
Ch3m	-21.96
Ch3y	-67.25
Ch5y	-95.11
Ch6m	-55.51
Change	-0.12%
Change From Open	-1.74
Close	56.57
Days Gap	1.64
Depreciation Amortization	21,000
Dollar Volume	1,413,404
Earnings Date	2026-05-22
Earnings Time	amc
EBIT	$-28.6M
EBITDA	$-28.6M
EPS	$-50.83
F Score	2
FCF	$-33.3M
FCF EV Yield	-31.89x
FCF Per Share	$-12.33
Financing CF	43,481,000
Fiscal Year End	December
Founded	2,014
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-09
Last Report Date	2025-12-31
Last Split Date	2025-08-07
Last Split Type	Reverse
Ma150	84.67
Ma150ch	-33.27%
Ma20	59.69
Ma20ch	-5.35%
Net CF	10,154,000
Next Earnings Date	2026-05-22
Open	57.5
Optionable	No
Position In Range	23.08
Post Close	56.5
Postmarket Change Percent	-0.87
Postmarket Price	$56.01
Ppne	666,000
Price Date	2026-05-08
Ptbv Ratio	3.59
Relative Volume	0.28x
Share Based Comp	2,574,000
Tr6m	-55.51%
Us State	California
Volume	25,016

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does SPRB pay a dividend?

Capital-return profile for this ticker.

Performance

SPRB stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SPRB?

Insider, institutional, and short-interest positioning.

Institutional ownership

+34.3%

Float: +96.3% of shares outstanding

Insider ownership

+3.7%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

SPRB momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.1

Neutral momentum band

Price vs 200-day MA

-14.0%

50/200-day relationship not available

Beta (5Y)

3.31

More volatile than the market

Sharpe ratio

1.02

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SPRB

Hub-level FAQ points readers to the deeper analysis pages.

What is the current SPRB stock rating?

Spruce Biosciences, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full SPRB analysis?

The full report lives at /stocks/SPRB/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for SPRB?

The latest report frames SPRB around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the SPRB page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.